Latest News
Clinical trials demonstrate that AstraZeneca's Farxiga reduces risk of cardiovascular death
Clinical trial results showed that AstraZeneca's Farxiga treatment against Type II diabetes significantly reduced the risk of cardiovascular death or worsening of heart failure in patients with mildly reduced or preserved ejection fraction.
Bunzl H1 profits grow, Dechra buys California-based Med-Pharmex
London pre-open The FTSE 100 was called to open 12 points lower at 7,415.
Tuesday newspaper round-up: Hospitality, energy costs, recession, broadband
Thousands of pubs face closure without urgent government support to soften the blow from soaring energy bills, the beer industry has said, putting jobs at risk in a sector still battling to recover from the Covid pandemic. The bosses of companies owning almost half of the UK’s 47,000 pubs said tenants were already giving notice because they could not cope with energy bills, which are due to rise more than fivefold in some cases. – Guardian.